Which has stronger earnings & valuation, HUM or CI?

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.31 $1.19B $9.35 35.45 Cigna Group $274.90B 0.26 $5.96B $23.59 11.63

Is HUM or CI more profitable?

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.82% 10.45% 3.75% Cigna Group 2.26% 19.75% 5.30%

Does the media prefer HUM or CI?

In the previous week, Cigna Group had 22 more articles in the media than Humana. MarketBeat recorded 29 mentions for Cigna Group and 7 mentions for Humana. Cigna Group's average media sentiment score of 1.21 beat Humana's score of 0.88 indicating that Cigna Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cigna Group 20 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CNC or HUM?

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centene $198.10B 0.15 -$6.67B -$13.14 N/A Humana $129.66B 0.31 $1.19B $9.35 35.45

Is CNC or HUM more profitable?

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Centene -3.25% 5.57% 1.54% Humana 0.82% 10.45% 3.75%

Does the media prefer CNC or HUM?

In the previous week, Humana had 3 more articles in the media than Centene. MarketBeat recorded 7 mentions for Humana and 4 mentions for Centene. Centene's average media sentiment score of 0.93 beat Humana's score of 0.88 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Humana 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ELV or HUM?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.43 $5.66B $23.51 16.77 Humana $129.66B 0.31 $1.19B $9.35 35.45

Is ELV or HUM more profitable?

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Elevance Health 2.62% 15.58% 5.57% Humana 0.82% 10.45% 3.75%

Does the media refer more to ELV or HUM?

In the previous week, Elevance Health had 9 more articles in the media than Humana. MarketBeat recorded 16 mentions for Elevance Health and 7 mentions for Humana. Elevance Health's average media sentiment score of 1.52 beat Humana's score of 0.88 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 15 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Humana 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, MOH or HUM?

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Molina Healthcare $45.08B 0.21 $472M $3.38 54.89 Humana $129.66B 0.31 $1.19B $9.35 35.45

Does the media favor MOH or HUM?

In the previous week, Molina Healthcare had 2 more articles in the media than Humana. MarketBeat recorded 9 mentions for Molina Healthcare and 7 mentions for Humana. Molina Healthcare's average media sentiment score of 1.24 beat Humana's score of 0.88 indicating that Molina Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Molina Healthcare 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Humana 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, UNH or HUM?

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio UnitedHealth Group $449.71B 0.78 $12.06B $13.24 29.14 Humana $129.66B 0.31 $1.19B $9.35 35.45

Does the media refer more to UNH or HUM?

In the previous week, UnitedHealth Group had 68 more articles in the media than Humana. MarketBeat recorded 75 mentions for UnitedHealth Group and 7 mentions for Humana. UnitedHealth Group's average media sentiment score of 1.01 beat Humana's score of 0.88 indicating that UnitedHealth Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UnitedHealth Group 49 Very Positive mention(s) 6 Positive mention(s) 14 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Positive Humana 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Humana (HUM) Competitors

$326.90 +6.03 (+1.88%)

As of 02:03 PM Eastern

Compare

HUM vs. CI, CNC, ELV, MOH, and UNH

Should you buy Humana stock or one of its competitors? MarketBeat compares Humana with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), and UnitedHealth Group (UNH). These companies are all part of the "managed health care" industry.

How does Humana compare to Cigna Group?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.3%. Humana pays out 37.9% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.31	$1.19B	$9.35	35.45
Cigna Group	$274.90B	0.26	$5.96B	$23.59	11.63

Humana has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market.

92.4% of Humana shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.2% of Humana shares are held by company insiders. Comparatively, 0.6% of Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Humana presently has a consensus price target of $276.17, suggesting a potential downside of 16.68%. Cigna Group has a consensus price target of $338.30, suggesting a potential upside of 23.26%. Given Cigna Group's stronger consensus rating and higher probable upside, analysts plainly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18
Cigna Group	0 Sell rating(s)	6 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.76

In the previous week, Cigna Group had 22 more articles in the media than Humana. MarketBeat recorded 29 mentions for Cigna Group and 7 mentions for Humana. Cigna Group's average media sentiment score of 1.21 beat Humana's score of 0.88 indicating that Cigna Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	20 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Cigna Group	2.26%	19.75%	5.30%

Summary

Cigna Group beats Humana on 16 of the 20 factors compared between the two stocks.

How does Humana compare to Centene?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Centene has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market. Comparatively, Humana has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$198.10B	0.15	-$6.67B	-$13.14	N/A
Humana	$129.66B	0.31	$1.19B	$9.35	35.45

In the previous week, Humana had 3 more articles in the media than Centene. MarketBeat recorded 7 mentions for Humana and 4 mentions for Centene. Centene's average media sentiment score of 0.93 beat Humana's score of 0.88 indicating that Centene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-3.25%	5.57%	1.54%
Humana	0.82%	10.45%	3.75%

93.6% of Centene shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Centene presently has a consensus target price of $58.94, suggesting a potential downside of 1.01%. Humana has a consensus target price of $276.17, suggesting a potential downside of 16.68%. Given Centene's stronger consensus rating and higher probable upside, equities analysts plainly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.37
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Elevance Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Humana has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Humana	0.82%	10.45%	3.75%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Humana pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.77
Humana	$129.66B	0.31	$1.19B	$9.35	35.45

In the previous week, Elevance Health had 9 more articles in the media than Humana. MarketBeat recorded 16 mentions for Elevance Health and 7 mentions for Humana. Elevance Health's average media sentiment score of 1.52 beat Humana's score of 0.88 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	15 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Humana	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health currently has a consensus price target of $407.05, suggesting a potential upside of 3.23%. Humana has a consensus price target of $276.17, suggesting a potential downside of 16.68%. Given Elevance Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

Elevance Health beats Humana on 16 of the 19 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$45.08B	0.21	$472M	$3.38	54.89
Humana	$129.66B	0.31	$1.19B	$9.35	35.45

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by company insiders. Comparatively, 0.2% of Humana shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Humana has a net margin of 0.82% compared to Molina Healthcare's net margin of 0.42%. Humana's return on equity of 10.45% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	0.42%	8.76%	2.32%
Humana	0.82%	10.45%	3.75%

Molina Healthcare currently has a consensus target price of $178.53, indicating a potential downside of 3.77%. Humana has a consensus target price of $276.17, indicating a potential downside of 16.68%. Given Molina Healthcare's higher probable upside, equities research analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18

Molina Healthcare has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Comparatively, Humana has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

In the previous week, Molina Healthcare had 2 more articles in the media than Humana. MarketBeat recorded 9 mentions for Molina Healthcare and 7 mentions for Humana. Molina Healthcare's average media sentiment score of 1.24 beat Humana's score of 0.88 indicating that Molina Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Humana beats Molina Healthcare on 9 of the 16 factors compared between the two stocks.

How does Humana compare to UnitedHealth Group?

UnitedHealth Group (NYSE:UNH) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

In the previous week, UnitedHealth Group had 68 more articles in the media than Humana. MarketBeat recorded 75 mentions for UnitedHealth Group and 7 mentions for Humana. UnitedHealth Group's average media sentiment score of 1.01 beat Humana's score of 0.88 indicating that UnitedHealth Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UnitedHealth Group	49 Very Positive mention(s)	6 Positive mention(s)	14 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Positive
Humana	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

UnitedHealth Group has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Humana has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UnitedHealth Group	$449.71B	0.78	$12.06B	$13.24	29.14
Humana	$129.66B	0.31	$1.19B	$9.35	35.45

UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.3%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Humana pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has a net margin of 2.68% compared to Humana's net margin of 0.82%. UnitedHealth Group's return on equity of 14.65% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UnitedHealth Group	2.68%	14.65%	4.77%
Humana	0.82%	10.45%	3.75%

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.3% of UnitedHealth Group shares are held by insiders. Comparatively, 0.2% of Humana shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

UnitedHealth Group presently has a consensus price target of $399.50, suggesting a potential upside of 3.56%. Humana has a consensus price target of $276.17, suggesting a potential downside of 16.68%. Given UnitedHealth Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe UnitedHealth Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UnitedHealth Group	1 Sell rating(s)	6 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.74
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

UnitedHealth Group beats Humana on 16 of the 20 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUM vs. The Competition

Export

Metric	Humana	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$39.80B	$50.41B	$6.26B	$23.11B
Dividend Yield	1.08%	1.80%	2.69%	4.09%
P/E Ratio	35.45	22.93	22.37	31.03
Price / Sales	0.31	0.61	547.57	14.71
Price / Cash	13.64	22.77	42.31	24.78
Price / Book	2.25	2.61	9.79	4.68
Net Income	$1.19B	$1.46B	$3.56B	$1.07B
7 Day Performance	7.93%	-3.38%	-1.27%	-0.50%
1 Month Performance	41.74%	4.22%	3.58%	0.39%
1 Year Performance	42.01%	-8.26%	27.13%	25.64%

Humana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUM Humana	3.4574 of 5 stars	$326.91 +1.9%	$276.17 -15.5%	+38.8%	$39.26B	$129.66B	34.97	67,060	Analyst Forecast
CI Cigna Group	4.9754 of 5 stars	$286.06 -0.1%	$339.80 +18.8%	-13.5%	$75.67B	$274.90B	12.13	67,700	Positive News Analyst Forecast
CNC Centene	3.1926 of 5 stars	$59.15 +0.0%	$56.94 -3.7%	+9.2%	$29.21B	$198.10B	N/A	61,100	Analyst Forecast
ELV Elevance Health	4.4596 of 5 stars	$394.41 -0.1%	$399.32 +1.2%	+3.0%	$85.65B	$199.13B	16.78	97,100	Positive News Analyst Forecast
MOH Molina Healthcare	2.5631 of 5 stars	$184.08 0.0%	$176.00 -4.4%	-39.6%	$9.59B	$45.08B	54.46	19,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HUM) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Summary

How does Humana compare to Centene?

Summary

How does Humana compare to Elevance Health?

Summary

How does Humana compare to Molina Healthcare?

Summary

How does Humana compare to UnitedHealth Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Is HUM or CI a better dividend stock?

Which has stronger earnings & valuation, HUM or CI?

Which has more volatility & risk, HUM or CI?

Do insiders and institutionals hold more shares of HUM or CI?

Do analysts recommend HUM or CI?

Does the media prefer HUM or CI?

Is HUM or CI more profitable?

Summary

How does Humana compare to Centene?

Which has more volatility & risk, CNC or HUM?

Which has stronger earnings & valuation, CNC or HUM?

Does the media prefer CNC or HUM?

Is CNC or HUM more profitable?

Do insiders & institutionals hold more shares of CNC or HUM?

Do analysts rate CNC or HUM?

Summary

How does Humana compare to Elevance Health?

Which has more volatility and risk, ELV or HUM?

Is ELV or HUM more profitable?

Do institutionals and insiders believe in ELV or HUM?

Is ELV or HUM a better dividend stock?

Which has preferable valuation and earnings, ELV or HUM?

Does the media refer more to ELV or HUM?

Do analysts prefer ELV or HUM?

Summary

How does Humana compare to Molina Healthcare?

Which has higher valuation and earnings, MOH or HUM?

Do insiders and institutionals believe in MOH or HUM?

Is MOH or HUM more profitable?

Do analysts rate MOH or HUM?

Which has more volatility and risk, MOH or HUM?

Does the media favor MOH or HUM?

Summary

How does Humana compare to UnitedHealth Group?

Does the media refer more to UNH or HUM?

Which has more volatility and risk, UNH or HUM?

Which has stronger earnings and valuation, UNH or HUM?

Is UNH or HUM a better dividend stock?

Is UNH or HUM more profitable?

Do insiders & institutionals believe in UNH or HUM?

Do analysts recommend UNH or HUM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools